TING-LEI GU,MEGHAN ANN TUCKER,HERBERT HAACK,KATHERINE ELEANOR CROSBY,VICTORIA MCGUINNESS RIMKUNAS
申请号：
PT14184691
公开号：
PT2881402T
申请日:
2010.02.12
申请国别(地区):
PT
年份:
2017
代理人:
摘要：
The invention provides the identification of the presence of mutant ROS protein in human cancer. In some embodiments, the mutant ROS are FIG-ROS fusion proteins comprising part of the FIG protein fused to the kinase domain of the ROS kinase. In some embodiments, the mutant ROS is the overexpression of wild-type ROS in cancerous tissues (or tissues suspected of being cancerous) where, in normal tissue of that same tissue type, ROS is not expressed or is expressed at lower levels. The mutant ROS proteins of the invention are anticipated to drive the proliferation and survival of cancers of the liver (including bile duct). The invention therefore provides, in part, isolated polynucleotides and vectors encoding the disclosed mutant ROS polypeptides (e.g., a FIG-ROS(S) fusion polypeptide), probes for detecting it, isolated mutant polypeptides, recombinant polypeptides, and reagents for detecting the fusion and truncated polypeptides. The identification of the mutant ROS polypeptides enables methods for inhibiting the progression of a cancer characterized by the mutant polynucleotides or polypeptides.
